Loading...
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL(+) leukemias
Acute and chronic leukemias, including CD34(+) CML cells, demonstrate increased expression of the Wilms tumor gene 1 product (WT1), making WT1 an attractive therapeutic target. However, WT1 is a currently undruggable, intracellular protein. ESKM is a human IgG1 T-cell receptor mimic monoclonal antib...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046427/ https://ncbi.nlm.nih.gov/pubmed/24723681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-01-549022 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|